Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells
- 1 April 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 6 (2), 227-239
- https://doi.org/10.1586/14760584.6.2.227
Abstract
(2007). Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Review of Vaccines: Vol. 6, No. 2, pp. 227-239.Keywords
This publication has 132 references indexed in Scilit:
- Epigallocatechin-3-Gallate Enhances CD8+ T Cell–Mediated Antitumor Immunity Induced by DNA VaccinationCancer Research, 2007
- Toll-Like Receptor Adaptor Molecules Enhance DNA-Raised Adaptive Immune Responses against Influenza and Tumors through Activation of Innate ImmunityJournal of Virology, 2006
- Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor ImmunityCancer Research, 2006
- Gene-based vaccines: recent technical and clinical advancesTrends in Molecular Medicine, 2006
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Comparison of HPV DNA vaccines employing intracellular targeting strategiesGene Therapy, 2004
- Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion geneGene Therapy, 2001
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989